Cosmetic cross-reference Noindex: medium evidence

32388-55-9

CAS 32388-55-9

32388-55-9 (CAS 32388-55-9) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
0
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
32388-55-9
CAS Number
32388-55-9
UNII
X6I62755AK
InChIKey
YBUIAJZFOGJGLJ-SWRJLBSHSA-N
ChEMBL ID
CHEMBL3184309
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
Synonyms and normalized names
ACETYL CEDRENE
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE NLM RxNorm 1 name row

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
ACETYL CEDRENE 2289006 SU MTHSPL
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is 32388-55-9 used for in pharmaceutical contexts?

32388-55-9 (CAS 32388-55-9) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for 32388-55-9?

No adverse-event association or SIDER side-effect rows are rendered for 32388-55-9 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is 32388-55-9 also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Acetylcedrene with EU status "restricted".

What clinical phase is 32388-55-9 in?

No phase 1-4 clinical development badge is rendered for 32388-55-9 because the matched compound identifier rows do not contain a max-phase value.